Search

everythinglearnresearchcommunity

for

Search:↓

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

A patient with granuloma annulare experienced both isotopic and isomorphic responses, with skin lesions responding to steroids but relapsing after stopping treatment.

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Lithium can cause skin changes similar to mycosis fungoides.

Rare skin cancer can mimic hair loss conditions, so thorough diagnosis is crucial.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

SH-SY5Y cell lysate is effective for diagnosing Satoyoshi syndrome.

Immune cells boost stem cell activity in hairy moles, causing more hair growth.

Syringomas likely start in the upper dermis and form distinct luminal structures.

There's an urgent need for better treatments for hair loss caused by radiation therapy.

Alopecia areata and polymyalgia rheumatica may be linked autoimmune conditions.

Ocrelizumab may cause total body hair loss in some patients.

Replacing defective mesenchymal cells with normal ones fixes thymic growth issues in 22q11.2DS mouse models.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Tumor cells in calcifying epithelioma of Malherbe resemble hair follicle cells.

Panniculitis in dermatomyositis is rare, more common in women, and may persist despite treatment.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

A rare skin condition in a boy is likely due to a specific genetic mutation pattern.

Mesotherapy is generally safe but can cause adverse reactions due to its varied use and lack of standardization; individualized treatment is needed for these complications.

Recognizing specific markers is crucial for correctly diagnosing and treating rare multifocal MPTT in males.

Scalp melanomas are more dangerous and often missed, needing earlier detection.

Excimer laser therapy can be an alternative for treating superficial morphea when topical steroids don't work.

Mesotherapy is a skin injection therapy used for pain and local conditions, with scientific support but needing more clinical trials.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.